Literature DB >> 9267263

Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions.

M B Acheson1, R G Patton, R L Howisey, R F Lane, A Morgan.   

Abstract

OBJECTIVE: To examine the histologic correlation between image-guided large-core needle biopsy (LCNB) and excisional biopsy of nonpalpable breast lesions.
DESIGN: Histologic findings of LCNB and excision specimens were reviewed for patients who underwent image-guided LCNB of nonpalpable breast lesions from April 1, 1993, to March 31, 1996. Histologic diagnosis of the excision specimen was used as a criterion standard. Follow-up ranged from 1 to 4 years. SETTINGS: A dedicated breast imaging clinic on the campus of an urban community hospital. PATIENTS: Five hundred fifty-two patients with nonpalpable mammographically detected abnormalities. MAIN OUTCOME MEASURES: Histologic diagnoses of LCNB and excision specimens (part of a prospectively designed, ongoing quality audit process).
RESULTS: Histologic findings were benign in 389 LCNB specimens (70.5%) and abnormal in 163 (29.5%). The benign LCNB specimens remained benign on clinical and radiologic follow-up, with 1 missed malignant diagnosis. One hundred seventy-three patients underwent excision following LCNB, resulting in 10 benign and 163 abnormal specimens. Diagnoses of 102 LCNB specimens showing invasive cancer were confirmed on excision. Of 54 patients in whom LCNB specimens showed ductal carcinoma in situ (DCIS), 10 showed DCIS plus invasive cancer on excision. Of 6 patients in whom LCNB specimens showed atypical duct hyperplasia (ADH), 1 was benign, 1 showed ADH and invasive cancer, 3 showed ADH and DCIS, and 1 remained ADH exclusively on excision. The histologic diagnosis for 10 benign LCNBs remained benign after excision. Correlation coefficient was 0.93 (P < .001).
CONCLUSIONS: Benign disease and invasive cancer of the breast can be diagnosed with a high level of confidence using image-guided LCNB. The histologic diagnosis for patients whose LCNB specimens show ADH or DCIS may change after excision.

Entities:  

Mesh:

Year:  1997        PMID: 9267263     DOI: 10.1001/archsurg.1997.01430320017002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

1.  Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance.

Authors:  Cholatip Wiratkapun; Pachara Patanajareet; Bussanee Wibulpholprasert; Panuwat Lertsithichai
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

2.  Intraoperative ultrasound-guided excision of nonpalpable breast lesions.

Authors:  I C Bennett; J Greenslade; H Chiam
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

3.  Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions.

Authors:  Shin-Cheh Chen; Horng-Ren Yang; Tsann-Long Hwang; Miin-Fu Chen; Yun-Chung Cheung; Swei Hsueh
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

4.  Clinical feasibility of microscopically-guided breast needle biopsy using a fiber-optic probe with computer-aided detection.

Authors:  Adam M Zysk; Freddy T Nguyen; Eric J Chaney; Jan G Kotynek; Uretz J Oliphant; Frank J Bellafiore; Patricia A Johnson; Kendrith M Rowland; Stephen A Boppart
Journal:  Technol Cancer Res Treat       Date:  2009-10

5.  The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer.

Authors:  Tao Sun; Hanwen Zhang; Wei Gao; Qifeng Yang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

6.  Atypical Ductal Hyperplasia: Risk Factors for Predicting Pathologic Upgrade on Excisional Biopsy.

Authors:  Ko Woon Park; Boo-Kyung Han; Sun Jung Rhee; Soo Youn Cho; Eun Young Ko; Eun Sook Ko; Ji Soo Choi
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.